Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
213M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
22M
-
Shares change
-
+1.44M
-
Total reported value, excl. options
-
$149M
-
Value change
-
+$9.8M
-
Put/Call ratio
-
0.36
-
Number of buys
-
39
-
Number of sells
-
-17
-
Price
-
$6.75
Significant Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q2 2018
80 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") as of Q2 2018.
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22M shares
of 213M outstanding shares and own 10.34% of the company stock.
Largest 10 shareholders include FMR LLC (3.24M shares), SUMMER ROAD LLC (3.03M shares), JENNISON ASSOCIATES LLC (2.32M shares), Versant Venture Management, LLC (2.22M shares), BlackRock Inc. (1.97M shares), WELLINGTON MANAGEMENT GROUP LLP (1.51M shares), VANGUARD GROUP INC (1.34M shares), SV Health Investors, LLC (1.25M shares), Opaleye Management Inc. (1.11M shares), and DELTEC ASSET MANAGEMENT LLC (533K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.